Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: Nodal metastases (N+) are one of the most powerful predictors of disease recurrence after surgery for non-functioning pancreatic neuroendocrine tumors (NF-PanNETs). However, the prognostic role of nodal metastases
Conference:
Presenting Author: Andreasi V
Authors: Andreasi V, Partelli S, Schiavo Lena M, Muffatti F, Battistella A,
Keywords: nodal metastases, micrometastases, surgery, prognosis, recurrence, pancreatic neuroendocrine,
Introduction: Pancreatic Neuroendocrine Tumors (pNETs) are rare neoplasms, often indolent in nature. Surgery is the backbone of curative treatment for localised panNETs. As the majority of these patients are cured by surgery, the development of long-term complications such as post-operative pancreatic insufficiency is critical.
Conference:
Presenting Author: Battistella A
Authors: Battistella A, Partelli S, Andreasi V, Muffatti F, Tamburrino D,
Keywords: PanNET, post-operative pancreatic insufficiency, distal pancreatectomy,
Introduction: Nodal metastases are one of the most powerful predictors of disease recurrence after surgery for non-functioning pancreatic neuroendocrine tumors (NF-PanNETs). However, the prognostic role of nodal metastases measuring
Conference:
Presenting Author:
Authors: Andreasi V, Partelli S, Muffatti F, Giannone F, Palumbo D,
Keywords: PanNET, nodal metastases, surgery, recurrence, micro metastasis,
Introduction: Non-functioning (NF), sporadic, G1-G2 pancreatic neuroendocrine tumors (PanNETs) usually display an indolent course. Surgery is the first-choice treatment for localized tumors >2 cm. Unresectable or metastatic PanNETs expressing somatostatin receptors (SSTRs) are treated with somatostatin analogues (SSAs). The PROMID and the CLARINET studies proved the SSA antiproliferative effect in advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The standard treatment for patients with PanNETs ≤2cm is active surveillance (AS). Yet no evidence of the value of SSA treatment exist in such patient population.
Conference:
Presenting Author: Maratta M
Authors: Maratta M, Chiloiro S, Raia S, Maiorano B, Rossi E,
Keywords: PanNET, somatostatin analogues, efficacy, surveillance, medical treatment,
Introduction: Nodal recurrence occurs in a significant proportion of patients submitted to curative surgery for non-functioning pancreatic neuroendocrine tumors (NF-PanNETs). However, its determinants have been poorly investigated.
Conference:
Presenting Author: Peralta Ferreira M
Authors: Peralta Ferreira M, Andreasi V, Muffatti F, Crippa S, Tamburrino D,
Keywords: pancreatic neuroendocrine tumor, curative surgery, nodal recurrence, distant recurrence, number of positive lymph nodes,